Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 5/2010

01-10-2010 | Short Research Report

GPs’ views on patient drug use and the pharmacist’s role in DRP management

Authors: Tommy Westerlund, Jan-Olof Brånstad

Published in: International Journal of Clinical Pharmacy | Issue 5/2010

Login to get access

Abstract

Objective The aim of this study was to examine general practitioners’ (GPs’) views on (1) patients’ drug-related problems (DRPs) and noncompliance and (2) the role of pharmacy practitioners in DRP management. Method A brief questionnaire was designed and distributed to 224 GPs in Sweden. Results Totally 152 GPs responded (68%). Most felt that pharmacy practitioners could improve patients’ drug use by identifying DRPs. A majority of the GPs also found presentations and analyses of their local pharmacies’ DRP documentation valuable. According to the GPs’ experiences, adverse drug effects and therapy failure were the most salient problems in patients’ drug use. Half of the doctors believed that 50–75% of their patients were compliant with their prescribed drug treatments. A majority of the GPs found a 75–95% degree of compliance acceptable. Conclusion The surveyed GPs demonstrated very positive attitudes towards the role of pharmacy practitioners in improving patients’ drug use and managing DRPs. The GPs realised that many patients were not compliant with their prescribed drug treatments and accepted an imperfect compliance.
Literature
1.
go back to reference Chen TF, Crampton M, Krass I, Benrimoj SI. Collaboration between community pharmacists and GPs in innovative clinical services—a conceptual model. J Soc Adm Pharm. 1999;16:134–44. Chen TF, Crampton M, Krass I, Benrimoj SI. Collaboration between community pharmacists and GPs in innovative clinical services—a conceptual model. J Soc Adm Pharm. 1999;16:134–44.
2.
go back to reference Zillich AJ, Milchak JL, Carter BL, Doucette WR. Utility of a questionnaire to measure physician–pharmacist collaborative relationships. J Am Pharm Assoc (2003). 2006;46:453–8.CrossRef Zillich AJ, Milchak JL, Carter BL, Doucette WR. Utility of a questionnaire to measure physician–pharmacist collaborative relationships. J Am Pharm Assoc (2003). 2006;46:453–8.CrossRef
3.
go back to reference Bradshaw SJ, Doucette WR. Community pharmacists as patient advocates: physician attitudes. J Am Pharm Assoc. 1998;38:598–602. Bradshaw SJ, Doucette WR. Community pharmacists as patient advocates: physician attitudes. J Am Pharm Assoc. 1998;38:598–602.
4.
go back to reference Ranelli PL, Biss J. Physicians’ perceptions of communication with and responsibilities of pharmacists. J Am Pharm Assoc. 2000;40:625–30. Ranelli PL, Biss J. Physicians’ perceptions of communication with and responsibilities of pharmacists. J Am Pharm Assoc. 2000;40:625–30.
5.
go back to reference World Health Organization. Adherence to long-term therapies. Evidence for action. WHO/MNC/03.01. Geneva, 2003. World Health Organization. Adherence to long-term therapies. Evidence for action. WHO/MNC/03.01. Geneva, 2003.
6.
go back to reference Krigsman K, Bastholm Rahmner P, Fuchs R, Nordström-Torpenberg I, Pettersson S, Nilsson JLG. Rational use of medicine. Use of concordance to improve patient adherence. WHO Drug Inf. 2007;21(1):27–32. Krigsman K, Bastholm Rahmner P, Fuchs R, Nordström-Torpenberg I, Pettersson S, Nilsson JLG. Rational use of medicine. Use of concordance to improve patient adherence. WHO Drug Inf. 2007;21(1):27–32.
7.
go back to reference Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc. 2001;41:192–9. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc. 2001;41:192–9.
8.
go back to reference Westerlund LOT, Björk HT. Pharmaceutical care in community pharmacies: practice and research in Sweden. Ann Pharmacother. 2006;40:1162–9. Epub 30 May 2006.CrossRefPubMed Westerlund LOT, Björk HT. Pharmaceutical care in community pharmacies: practice and research in Sweden. Ann Pharmacother. 2006;40:1162–9. Epub 30 May 2006.CrossRefPubMed
10.
go back to reference Márquez Contreras E, de la Figuera von Wichmann M, Roig Ponsa L, Naval Chamosa J. El cumplimiento terapéutico en la hypertensión arterial en España, según la opinión de los médicos de familia. Proyecto Cumplex. [Compliance with hypertension therapy in Spain, according to the views of family doctors. Complex project.]. Aten Primaria. 2007;39:417–23. (in Spanish).CrossRefPubMed Márquez Contreras E, de la Figuera von Wichmann M, Roig Ponsa L, Naval Chamosa J. El cumplimiento terapéutico en la hypertensión arterial en España, según la opinión de los médicos de familia. Proyecto Cumplex. [Compliance with hypertension therapy in Spain, according to the views of family doctors. Complex project.]. Aten Primaria. 2007;39:417–23. (in Spanish).CrossRefPubMed
Metadata
Title
GPs’ views on patient drug use and the pharmacist’s role in DRP management
Authors
Tommy Westerlund
Jan-Olof Brånstad
Publication date
01-10-2010
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 5/2010
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-010-9408-7

Other articles of this Issue 5/2010

International Journal of Clinical Pharmacy 5/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.